Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay ; volume:9 ; number:1 ; day:6 ; month:3 ; year:2019 ; pages:1-10 ; date:12.2019
Scientific reports ; 9, Heft 1 (6.3.2019), 1-10, 12.2019
- Urheber
-
Saludes, V.
Antuori, A.
Reinhardt, B.
Viciana, I.
Clavijo, E.
Schreiber, L.
Tenenbaum, M.
Rodriguez-Frias, F.
Quer, J.
Matas, L.
Martró, E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-40099-3
- URN
-
urn:nbn:de:101:1-2019032521223104543733
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Saludes, V.
- Antuori, A.
- Reinhardt, B.
- Viciana, I.
- Clavijo, E.
- Schreiber, L.
- Tenenbaum, M.
- Rodriguez-Frias, F.
- Quer, J.
- Matas, L.
- Martró, E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
New insight into HCV E1/E2 region of genotype 4a
Consensus siRNA for inhibition of HCV genotype-4 replication
Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh
Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
Genotype × environment interactions
PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection
NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
New insight into HCV E1/E2 region of genotype 4a
Consensus siRNA for inhibition of HCV genotype-4 replication
Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh
Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
Genotype × environment interactions
PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection
NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
New insight into HCV E1/E2 region of genotype 4a
Consensus siRNA for inhibition of HCV genotype-4 replication
Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh
Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
Genotype × environment interactions
PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection